Catalyst Health Ventures

About The Fund

Catalyst Health Ventures (CHV) is a specialized venture capital firm focused on early-stage investments in transformative medical technologies. Founded in 1998, the firm operates out of Braintree, Massachusetts and has developed a reputation for investing in companies that address critical, unmet healthcare needs. With deep expertise in the field of Equity, CHV specializes in Seed, Startup, and Early Stage investments, fostering growth and innovation in the healthcare ecosystem. Their investment portfolio showcases their commitment to advancing healthcare, life sciences, medical devices, diagnostics, instruments, and drug screening platforms sectors. CHV exhibits a keen focus on therapeutic medical devices, diagnostics, and digital health, particularly emphasizing innovative technologies poised to significantly improve patient outcomes and set new standards of care. The team at CHV, comprised of industry professionals like Darshana Zaveri and Joshua S. Phillips who are Founders and Managing Partners, alongside David Mackey as CFO, leverages their collective experience to mentor and support portfolio companies in navigating the unique challenges of the healthcare industry. CHV's website highlights their commitment to ''Building a Healthier Future Together'' by investing in MedTech solutions that are transformative and meet the dire needs of healthcare globally. Their portfolio encompasses a broad spectrum of healthcare and wellness-related enterprises, embodying CHV's comprehensive approach to investment and their strategic vision for the industry. Their involvement with companies such as Sera Prognostics, which presents groundbreaking study results at prominent medical meetings, exemplifies CHV's dedication to innovation and the dissemination of cutting-edge healthcare solutions.